Category: Pharma News
The NPPA sets the retail price of 74 new medications and the ceiling pricing for 79 scheduled formulations.
Based on the National List of Essential Medicines (NLEM), 2022, the National Pharmaceutical Pricing Authority (NPPA) updated and…
Laevoroc’s LR 09 is given orphan medication classification by the US FDA to treat leukaemia relapse following allogeneic stem cell transplant.
LR 09, a novel metabolic immune checkpoint inhibitor, has been given Orphan Drug Designation by the US Food…
Clinical testing of JWATM214 by JW Therapeutics in people with advanced hepatocellular carcinoma has begun.
The first patient infusion and the start of a clinical investigation of JWATM214 in people with advanced hepatocellular…
The purpose of CDSCO’s show-cause notices to owners of online pharmacies has raised doubt among the AICDF.
The All India Organisation of Chemists and Druggists (AIOCD), which claims to have more than 10 lakh members…
In order to treat AS and RA, Enzene Biosciences has started selling biosimilar adalimumab commercially in India.
Adalimumab has started to be sold commercially for the treatment of rheumatoid arthritis and ankylosing spondylitis, according to…
At one year in the ADAPT research, the MiniMed 780G system outperforms numerous daily injections with CGM for the management of type 1 diabetes.
The performance of the MiniMed 780G advanced hybrid closed loop system (AHCL) versus multiple daily insulin injections (MDI)…
The US FDA has authorised COVI-Go, a COvid-19 fast antigen self-test, for emergency use at home.
Mologic Inc., a leading provider of lateral flow and quick diagnostic technologies, products, and services, disclosed that the…
IISc researchers develop novel brain imaging technology to find cell components that are now undetectable to microscopes.
Researchers from the Indian Institute of Science (IISc), Bengaluru demonstrate how a brain-inspired image sensor can identify minute…
To accelerate the research and development of medical devices for commercialization, the ICMR has shortlisted three companies for the mPRiDE initiative.
The Product Ignition & Development Enabler (mPRiDE) programme of the Indian Council of Medical Research (ICMR) has shortlisted…
ICMR has issued an invitation to makers of vaccines to formulate a vaccine against Kyasanur Forest Disease
The Kyasanur Forest Disease Vaccine (KFDV) isolate will be used in R&D activities by experienced vaccine manufacturers, pharmaceutical…
